10.02.2011 - Sanofi Aventis Chief Executive Chris Viehbacher said in an interview that the French pharmaceuticals group's offer for Genzyme could be extended for a third time, beyond the Feb...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)